Catalyst Pharmaceuticals, Inc.

CPRXNASDAQHealthcare● Active

$31.30

+$0.03(+0.08%)

Market Cap$3.8B

P/E Ratio—

52W High$32.56

52W Low$19.05

Avg Volume2.1M

Open$31.28

Beta0.74

Overview

Catalyst Pharmaceuticals, Inc. (CPRX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CPRX · net income · updated Jun 8, 2026

Core profitability metrics

CPRX · net income · margin · TTM · CAGR

Net income was $214.3M for FY2025 (fiscal year ending 2025-12-31), up 30.8% year-over-year. Net profit margin was 36.4%. Based on available data, Catalyst Pharmaceuticals, Inc. has been profitable since at least 2019.

FY2025 Net Income$214.3M▲ +30.8% YoY

Trailing 12M (TTM)$221.3Mtrailing 4 quarters sum

Net Profit Margin36.4%$214.3M ÷ $589.0M

YoY Change+30.8%—

5-Year CAGR+23.4%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2019

▸ FMP /income-statement · Annual · CPRX net income history · CPRX profit margin

Annual net income data

CPRX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$214.3M▲ +30.8%36.4%$589.0M

FY2024$163.9M▲ +129.5%33.3%$491.7M

FY2023$71.4M▼ 14.0%17.9%$398.2M

FY2022$83.1M▲ +110.4%38.8%$214.2M

FY2021$39.5M▼ 47.3%28.0%$140.8M

Net income vs peers (Healthcare)

CPRX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Catalyst Pharmaceuticals, Inc.YOU

CPRX

$214.3M+30.8%36.4%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Catalyst Pharmaceuticals, Inc. (CPRX) reported net income of $214.3M for FY2025 (fiscal year ending 2025-12-31), up 30.8% year-over-year. The net profit margin was 36.4% — meaning the company kept $0.36 of every dollar of revenue as profit.

Based on available data, Catalyst Pharmaceuticals, Inc. has been profitable since at least 2019. Net income reached a peak of $214.3M in FY2025. Data available for 15 fiscal years.

Catalyst Pharmaceuticals, Inc.'s net profit margin was 36.4% for FY2025, based on the latest annual results.

Investors sometimes search for "Catalyst Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from CPRX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CPRX net income · 5 questions

Catalyst Pharmaceuticals, Inc. is profitable. The company reported net income of $214.3M for FY2025, a net profit margin of 36.4%. Net income was up 30.8% year-over-year. Based on available data, Catalyst Pharmaceuticals, Inc. has been profitable since at least 2019.

is CPRX profitabledoes CPRX make a profitCPRX profitabilityCPRX profitable company

▸ Source: FMP /income-statement · GAAP · Catalyst Pharmaceuticals, Inc. · Catalyst Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026